BRUNI, Alessio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.261
NA - Nord America 3.507
EU - Europa 1.476
SA - Sud America 595
Continente sconosciuto - Info sul continente non disponibili 111
AF - Africa 72
OC - Oceania 7
Totale 10.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.344
CN - Cina 1.322
SG - Singapore 1.140
IT - Italia 634
VN - Vietnam 500
BR - Brasile 452
HK - Hong Kong 366
BD - Bangladesh 271
KR - Corea 222
GB - Regno Unito 172
TR - Turchia 162
FI - Finlandia 133
DE - Germania 95
SE - Svezia 88
FR - Francia 78
CA - Canada 72
IN - India 62
ID - Indonesia 58
AR - Argentina 48
MX - Messico 47
RU - Federazione Russa 45
UA - Ucraina 44
NL - Olanda 35
BG - Bulgaria 26
ES - Italia 25
IQ - Iraq 25
CO - Colombia 23
JP - Giappone 22
EC - Ecuador 21
BE - Belgio 20
CL - Cile 19
PL - Polonia 19
ZA - Sudafrica 17
MY - Malesia 14
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
VE - Venezuela 11
DZ - Algeria 10
PY - Paraguay 10
EG - Egitto 9
IE - Irlanda 8
KE - Kenya 8
SA - Arabia Saudita 8
LT - Lituania 7
NP - Nepal 7
AL - Albania 6
AU - Australia 6
CR - Costa Rica 6
IL - Israele 6
PE - Perù 6
PH - Filippine 6
RO - Romania 6
TH - Thailandia 6
TN - Tunisia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
HN - Honduras 5
JO - Giordania 5
PA - Panama 5
AT - Austria 4
BZ - Belize 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
IR - Iran 4
JM - Giamaica 4
MA - Marocco 4
QA - Qatar 4
RS - Serbia 4
UZ - Uzbekistan 4
BO - Bolivia 3
DK - Danimarca 3
KZ - Kazakistan 3
LU - Lussemburgo 3
SN - Senegal 3
SV - El Salvador 3
TG - Togo 3
TT - Trinidad e Tobago 3
CH - Svizzera 2
CY - Cipro 2
GT - Guatemala 2
NI - Nicaragua 2
PR - Porto Rico 2
SC - Seychelles 2
SI - Slovenia 2
TW - Taiwan 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
Totale 9.901
Salva come PNG Salva come JPEG
Città #
Hefei 779
Singapore 637
Ashburn 478
Hong Kong 356
San Jose 333
Santa Clara 280
Seoul 222
Fairfield 213
Ho Chi Minh City 169
Council Bluffs 165
Istanbul 130
Hanoi 124
Beijing 121
Helsinki 121
Los Angeles 106
Houston 89
Wilmington 79
New York 77
Chandler 76
Woodbridge 76
Seattle 73
London 71
Chicago 65
Milan 65
Lauterbourg 64
Shanghai 64
Cambridge 63
Buffalo 59
Modena 53
Dallas 50
Kent 46
Rome 43
Southend 41
Boardman 38
Nyköping 38
São Paulo 37
The Dalles 35
Orem 28
Salt Lake City 28
Mexico City 27
Ann Arbor 25
Da Nang 24
Jakarta 24
Naples 24
Princeton 22
Sofia 21
Bologna 20
Dearborn 20
San Diego 20
Frankfurt am Main 19
Haiphong 19
Tokyo 18
Toronto 18
Jacksonville 17
Turin 17
Warsaw 17
Montreal 16
Brooklyn 15
Chennai 14
Dhaka 14
Leuven 14
Munich 14
Reggio Emilia 14
Biên Hòa 13
Florence 13
Denver 12
Elk Grove Village 12
Johannesburg 12
Lappeenranta 12
Las Vegas 12
Rio de Janeiro 12
Baghdad 11
Eugene 11
Osasco 11
Phoenix 11
Poplar 11
Tampa 11
Izmir 10
Nuremberg 10
Santiago 10
Shenzhen 10
Brasília 9
Charlotte 9
Curitiba 9
Manchester 9
Moscow 9
Portsmouth 9
Ankara 8
Brescia 8
Miano 8
Stockholm 8
Thái Nguyên 8
Tilburg 8
Verona 8
Atlanta 7
Falkenstein 7
Guangzhou 7
Guarulhos 7
Mudanya 7
Mumbai 7
Totale 6.401
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 335
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 319
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 303
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 277
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 270
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 248
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 214
SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment 212
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 203
Pineoblastoma in Adults: A Rare Case Successfully Treated with Multimodal Approach Including Craniospinal Irradiation Using Helical Tomotherapy 194
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 178
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC 175
Lattice Radiation Therapy in clinical practice: A systematic review 163
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 156
Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature 155
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients 153
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 152
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study 149
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis 147
Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation 147
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 141
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 135
Current radiotherapy techniques in NSCLC: challenges and potential solutions 135
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 134
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 134
The role of postoperative radiotherapy for thymomas: a multicentric retrosepective evaluation from three Italian centers and review of the literature. 133
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 132
Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial 127
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 126
Quality of life after prostate cancer diagnosis: Data from the Pros-IT CNR 126
Guidelines on prostate carcinoma - AIRO, 2016 125
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial 121
Erratum: The role of postoperative radiotherapy for thymomas: A multicentric retrospective evaluation from three Italian centers and review of the literature (Journal of Thoracic Disease (2020) 12 (7518-7530) DOI: 10.21037/jtd-2019-thym-09) 120
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 117
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 117
A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC 116
Non-invasive approach to treat primary solid solitary pulmonary nodule: a narrative review by the radiation oncologist perspective 116
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 112
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 111
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 108
Response to Letter to the Editor Titled “Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?” 107
How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national patterns-of-practice (pop) database by the uro-oncology study group of the italian society of radiotherapy and clinical oncology (airo) 107
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 105
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 105
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 104
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 101
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 99
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach 98
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 94
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 94
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 94
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 91
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study 89
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC 88
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 87
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 87
Radiosurgery Using Tomotherapy for Patients with Brain Oligo-metastasis: A Retrospective Analysis on Feasibility and Tolerance 87
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach 87
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings 86
Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience 85
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 82
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 79
Brain metastases from primary colorectal cancer: Is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) 79
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 78
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 77
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 77
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 75
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer 73
Post-operative radiotherapy in N2 non-small cell lung cancer: A retrospective analysis of 175 patients 72
Oral ibandronate in metastatic bone breast cancer: The Florence University experience and a review of the literature 69
Management of Stage II testicular seminoma over a period of 40 years 68
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: The impact of thoracic and brain irradiation on survival 68
Reirradiation in head and neck recurrent or second primary tumor: Efficacy, safety, and prognostic factors 68
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 65
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719) 64
Radiation therapy in small cell lung cancer: a national Italian survey 58
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: A retrospective analysis 57
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)—Lung Working Group 54
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial) 51
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study 49
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 47
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 47
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 41
Totale 10.029
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.144
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022405 59 25 15 15 14 25 27 31 39 31 93 31
2022/2023294 38 37 40 15 40 31 5 20 40 2 10 16
2023/2024257 18 13 24 31 21 12 22 40 8 15 15 38
2024/20251.715 30 2 17 62 158 133 46 78 171 314 355 349
2025/20266.383 505 406 702 791 607 406 609 305 662 457 491 442
2026/2027215 215 0 0 0 0 0 0 0 0 0 0 0
Totale 10.029